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ABSTRACT
Alisol B 23-acetate (AB23A), a natural triterpenoid from the rhizome of Alisma 
orientale, a Chinese medicinal herb, has multiple physiological activities including 
anticancer. However, its effect on human colon cancer and the underlying mechanism 
are not clear. Here, we reported for the first time that AB23A induced cell cycle G1 
phase arrest and apoptotic cell death in colon cancer cells. Autophagy also occurred 
in AB23A-treated HCT116 cells as evidenced by the accumulation of microtubule-
associated protein 1 light chain 3 form II (LC3-II) and degradation of SQSTM1/p62. 
An autophagy inhibitor, 3-methyladenine (3-MA) was found to attenuate AB23A-
mediated autophagy, apoptosis, and cell death, indicating that AB23A-induced 
apoptotic response was dependent on the induction of autophagy. In addition, 
the treatment of HCT116 cells with AB23A resulted in the generation of reactive 
oxygen species (ROS) and phosphorylation of c-Jun N-terminal kinase (JNK). A 
ROS scavenger, N-acetylcysteine (NAC) and a JNK-specific inhibitor, SP600125 
attenuated AB23A-induced autophagy and apoptotic cell death. Moreover, NAC was 
able to eliminate AB23A-induced JNK phosphorylation. This finding provides a novel 
mechanism of action of AB23A in colon cancer HCT116 cells that AB23A induces 
autophagic-dependent apoptotic cell death in colon cancer cells, at least in part, 
though the accumulation of intracellular ROS and subsequent activation of JNK.
INTRODUCTION
Natural products are important sources of 
novel anticancer agents and contribute a lot to cancer 
chemotherapy and chemoprevention [1]. Alisol B 
23-acetate (AB23A) (Figure 1A) is a protostane-type 
triterpenoid isolated from Alismatis Rhizoma which is 
a medicinal plant formulated into different traditional 
Chinese herbal medicine formulas and widely used in 
the treatment of urological diseases and other aliments. 
In recent years, many studies have revealed that 
AB23A possesses several pharmacological activities, 
including anti-hepatitis virus [2], antibacterial [3], and 
hepatoprotective effect [4, 5]. Furthermore, AB23A has 
attracted great attention for its potential anticancer effects.
Apoptosis, as the type-I programmed cell death 
(PCD), is a mechanism exploited by many anticancer 
drugs to cause cancer cell death. AB23A has been 
demonstrated to induce apoptotic cell death in human 
hepatoma Hep3B cells, vascular smooth muscle A7r5 
cells, human acute lymphoblastic leukemia CEM cells, 
and human hormone-resistant prostate cancer PC-3 cells 
[6–8]. Autophagy, a lysosomal catabolic pathway of self-
degradation and recycling of cellular macromolecules 
and organelles, is often involved in the response to the 
treatment with anticancer agents [9, 10]. In some cellular 
settings, autophagy serves as a cell survival pathway 
suppressing apoptosis, and in others, it can lead to cancer 
cell death both in cells that are capable of apoptotic cell 
death and in cells that are deficient in apoptotic cell death 
[11]. Whether AB23A can induce apoptosis or autophagy 
in AB23A-treated colon cancer cells remains to be 
determined.
Reactive oxygen species (ROS), some active 
forms of oxygen, are generated as by-products of cellular 
metabolism, primarily in the mitochondria [12]. Some 
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recent work has demonstrated that ROS function as 
second messengers participating into a wide variety of cell 
signaling pathways, including autophagy, apoptosis, gene 
expression, and the activation of cell signaling cascades, 
such as those involving mitogen-activated protein kinases 
(MAPK signal transduction cascades) [11, 13–15]. A 
moderate increase in ROS can promote cell proliferation 
and differentiation, whereas excessive cellular production 
of ROS can interfere with cellular signaling pathways by 
causing oxidative damage to cellular macromolecules 
such as lipids, proteins, and DNA [16–18]. Interestingly, 
some accumulating evidence suggests that cancer cells 
are frequently under increased burden of oxidative stress, 
and therefore more vulnerable to the damage promoted 
by further ROS insults induced by some exogenous 
agents [19]. Thus some chemical agents targeting of 
related signaling pathways, particularly the ROS/MAPK 
signaling, may be effective in the treatment of human 
cancers. However, the effect of AB23A-mediated ROS 
production and triggering of related signaling pathways in 
human colon cancer cells remain unclear.
Colon cancer is one of the most common 
malignancies worldwide. In the present study, we aimed 
to determine the anticancer activity of AB23A in human 
colon cancer SW620 and HCT116 cells. Cell viability 
assay, apoptosis assay, autophagy assay, ROS assay, 
western blot assay, and kinase inhibitors were employed 
to investigate the potential intracellular signal transduction 
pathways involved in AB23A-induced cell growth 
inhibition.
RESULTS AND DISCUSSION
AB23A inhibits cell proliferation in human colon 
cancer cells
Traditional Chinese herbal medicines have been 
considered as a rich source for the discovery of novel 
therapeutic agents with new structural features and 
mechanism of action due to thousands of years of history 
in clinical use. AB23A is a major ingredient isolated 
from the herb Alismatis rhizoma which has been used as 
a key ingredient in some traditional Chinese medicines 
for urological disease-related symptoms. In recent years, 
AB23A has been demonstrated to be an oral active 
component in the treatment of various kinds of diseases 
including nephritic syndrome, hemolysis, and allergy. 
It has also been reported that AB23A could induce cell 
apoptosis in leukemia and hepatoma cells [8]. Thus, 
AB23A has the potential to be a novel anticancer agent. In 
this study, we investigated the anticancer effect of AB23A 
in human colon cancer SW620 and HCT116 cells, which 
is the second leading cause of cancer death worldwide.
We first tested the effect of AB23A on cell 
proliferation in two human colon cancer cell lines. As 
shown in Figure 1B, after the exposure of SW620 and 
HCT116 cells to AB23A for 24 h, AB23A markedly 
inhibited the proliferation of SW620 and HCT116 in 
a dose-dependent manner with IC50 values of about 
20μM in these two cancer cell lines. In contrast, AB23A 
exhibited much lower cytotoxicity towards a normal 
colonic epithelial cell line, CCD-841CoN at the same 
concentrations as were used on cancer cells (Figure 1B). 
In addition, AB23A showed strong cytotoxicity against 
human kidney cancer cell line HEK293T, human gastric 
cancer cell line AGS, and human liver cancer cell line 
PLC8024 (Supplementary Figure 1). These findings 
prompted us to further evaluate the activity as well as 
action mechanism of AB23A in the colon cancer cell lines.
AB23A induces cell cycle G1 arrest in human 
colon cancer cells
The interference with cell cycle progression is one 
of the properties of many anticancer agents. AB23A has 
been shown to induce G1 phase cell cycle arrest in ovarian 
cancer cell lines before [20]. Thus the effect of AB23A on 
cell cycle profile of colon cancer cells was analyzed by 
flow cytometry in our study. As expected, the treatment 
with AB23A (20 μM) for 24 h was found to cause a 
substantial accumulation of cells at G1 phase in SW620 
and HCT116 cells (Figure 1C), indicating that AB23A 
arrested SW620 and HCT116 cells at G1 phase of the cell 
cycle and subsequently blocked cell growth.
AB23A induces apoptosis in SW620 and HCT116 
cells
In the past, accumulated data indicated that many 
anticancer drugs could induce apoptotic cell death in 
tumor cells. As AB23A has a steroid-like structure, it is 
expected that AB23A possesses some steroid-related 
pharmacological activities, such as glucocorticoid-
mediated apoptosis in murine T cell number and function 
[21]. As expected, the PI staining of cells treated with 
AB23A showed remarkable increased proportion of 
sub-G0/G1 cells (Figure 1C), indicating the induction of 
apoptosis in response to AB23A treatment. The induction 
of colon cancer cell apoptosis was also observed by 
employing Hoechst 33342 staining. The results showed 
that AB23A elicited appreciable apoptotic response in 
SW620 and HCT116 cells, as evidenced by the appearance 
of cells with nuclear condensation (Figure 2A). This 
was further confirmed by analyzing the expression of 
cleaved PARP. As shown in Figure 2B, cleaved PARP 
was observed notably in cells treated with AB23A for 
24 h. Moreover, a pan-caspase inhibitor, Z-VAD-FMK 
(Z-VAD) decreased cell death induced by AB23A (Figure 
2C) significantly. Hence, the cytotoxic effect of AB23A 
in human colon cancer SW620 and HCT116 cells is 
likely due to the induction of apoptosis. To quantify the 
apoptosis, cells treated with AB23A were stained with 
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Annexin V–FITC/PI and analyzed by flow cytometry. 
the exposure of cells to AB23A for 24 h resulted in a 
significantly increased percentage of apoptotic cells 
(Figure 2D). Collectively, these results suggested that 
AB23A exhibited potential anticancer activity, at least in 
part, by inducing apoptosis in colon cancer cells.
Excessive autophagy induced by AB23A leads to 
apoptotic cell death in HCT116 cells
We next asked whether AB23A induced autophagy 
in SW620 and HCT116 cells. Microtubule-associated 
protein 1 light chain 3 (LC3) is a mammalian protein that 
mainly exists in two forms, LC3-I and LC3-II. LC3-I in 
the cytosol is converted to the membrane-bound LC3-II 
during autophagosome formation. The levels of LC3-
II have been shown to correlate with the number of 
autophagosomes per cell [22]. The increased production 
of LC3-II has been used as indicators for autophagy 
induction [23]. Thus, we measured the expression levels 
of LC3-II by immunoblot assays. As shown in Figure 3A, 
the treatment of cells with AB23A resulted in significant 
increases of LC3-II level in HCT116 cells in a dose-
dependent manner. However, the treatment with AB23A 
did not change the expression of LC3-II in SW620 
cells. To further clarify the ability of AB23A to induce 
autophagy, we measured the expression of SQSTM1/p62, 
which is a selective substrate of autophagy [24]. In line 
Figure 1: AB23A inhibits cell proliferation and induces cell cycle G1 phase arrest in human colon cancer cells. (A) 
Chemical structure of AB23A. (B) Cell viability was determined after treatment with AB23A at various concentrations for 24 h. (C) SW620 
and HCT116 cells, treated with vehicle (DMSO) or 20μM of AB23A for 24 h, were analyzed for DNA contents by flow cytometry. Values 
are mean ± standard deviation, n=3. * p<0.05, **p<0.01.
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with the enhanced LC3 turnover, p62 expression level was 
significantly decreased after AB23A treatment in HCT116 
cells. These results strongly supported the induction of 
autophagy by AB23A in HCT116 colon cancer cells.
The induction of autophagy and apoptosis in 
HCT116 cells in response to AB23A treatment raised 
the question whether these two events were linked or 
independent events. When HCT116 cells were co-treated 
with AB23A and an autophagy inhibitor, 3-MA, cell 
viability was markedly improved in comparison with 
cells treated with AB23A alone (Figure 3B), suggesting 
that AB23A-induced HCT116 cell death was dependent 
on autophagy. Further, the treatment of cells with 3-MA 
resulted in not only a marked reduction of the level 
of LC3-II, but also a reduction of cleaved PARP and 
percentage of apoptotic cells in AB23A-treated cells 
(Figure 3C and 3D), suggesting that the ability of AB23A 
to elicit an apoptotic response was dependent on induction 
of autophagy. Collectively, AB23A induced autophagic-
dependent apoptotic cell death.
AB23A induces autophagy and apoptosis via 
ROS generation in HCT116 cells
The deregulation of cellular redox balance plays 
a pivotal role in the pro-apoptotic activities of various 
anticancer agents [25, 26]. The overproduction of ROS 
and free radicals can cause serious damage to lipids, 
proteins, and DNA, and regulate the process involved in 
initiating autophagy and apoptosis [27, 28]. Recently, it 
has been reported that ROS might be involved in steroid-
induced apoptosis of lymphocytes [29, 30]. We therefore 
tried to determine whether AB23A-induced cytotoxicity 
was associated with the production of intracellular ROS. 
As shown in Figure 4A, AB23A caused a dose-dependent 
increase of the level of intracellular ROS in HCT116 
Figure 2: AB23A induces apoptosis in colon cancer cells. (A) SW620 and HCT116 cells were treated with 20 μM of AB23A for 
24 h, stained with Hoechst 33342 and photographed by fluorescence microscopy. Bar, 10 μm. Arrows show the apoptotic cells. (B) After 
AB23A treatment at indicated concentrations for 24 h, the effect of AB23A on the PARP cleavage was examined by Western blot. (C) Cell 
viability was assessed in SW620 and HCT116 cells treated for 24 h with AB23A (20 μM) in the presence or absence of Z-VAD (20 μM). (D) 
SW620 and HCT116 cells were treated with AB23A at indicated concentrations for 24 h, stained with Annexin V–FITC/PI, and analyzed 
by flow cytometry. Percentages of apoptotic cells are presented in the histogram. Values are mean ± standard deviation, n=3, **p<0.01.
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Figure 3: Inhibition of autophagy protects HCT116 cells from AB23A-induced cell death and apoptosis. (A) SW620 and 
HCT116 cells were exposed to AB23A for 24 h at various concentrations. Then expression levels of LC3-I, LC3-II, and P62 were assessed 
by immunoblot analysis. (B) HCT116 cells were treated with AB23A (20 μM) in the absence or presence of 2 mM of 3-MA for 24h. Then 
cell viability was assessed by the cck-8 assay, (C) expression levels of LC3-I, LC3-II, and cleaved PARP were assessed by immunoblot 
analysis, and (D) the percentage of apoptosis was determined by flow cytometry. Values are mean ± standard deviation, n=3, *p<0.05, 
**p<0.01.
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Figure 4: ROS are involved in AB23A-induced autophagy and apoptosis. (A) HCT116 cells were treated with AB23A at 
various concentrations for 6 h, ROS levels were measured as DCF fluorescence intensity by flow cytometry. (B) HCT116 cells were 
pretreated with the ROS scavengers NAC (10 mM) for 1 h and then AB23A (20 μM) was included in the incubation for 6 h. ROS levels 
were measured by flow cytometry. (C) HCT116 cells were pre-incubated with NAC (10 mM) for 1 h, and then treated with AB23A (20 μM) 
for 24 h. Cell viability was measured by cck-8 kit. (D) Cells were treated with AB23A and NAC as in (C), before the percentage of apoptosis 
was determined by flow cytometry. (E) Cells were treated with AB23A and NAC as in (C), then expression levels of LC3-I, LC3-II, and 
cleaved PARP were measured by Western blot. Values are mean ± standard deviation, n=3, **p<0.01.
cells. The pre-treatment with a ROS scavenger, NAC 
for 1h significantly attenuated AB23A-induced ROS 
production and reversed AB23A-mediated cell growth 
inhibition (Figure 4B and 4C), suggesting AB23A elicited 
cytotoxicity through ROS generation. The mitochondria 
and NADPH oxidase system were considered as the major 
producers of ROS within the cells [12, 31, 32]. We next 
studied the effects of a mitochondria-targeted antioxidant, 
MitoTEMPOL (MitoT) and a NADPH oxidase inhibitor, 
apocynin on the AB23A-induced ROS generation and 
cytotoxicity. The results showed that MitoTEMPOL, but 
not apocynin, significantly attenuated AB23A-induced 
ROS production as well as inhibitory effect on HCT116 
cell growth (Supplementary Figure 2), suggesting AB23A 
induced ROS production via mitochondria pathway.
To clarify the role of ROS in mediating AB23A-
induced autophagy and apoptosis, we further analyzed 
the percentage of apoptotic cells and the expression level 
of LC3-II and cleaved PARP in the presence of NAC. As 
shown in Figure 4D, NAC significantly blocked AB23A 
induced apoptosis. In addition, Western blot analysis 
showed that NAC suppressed the increased expression 
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of LC3-II and cleaved PARP induced by AB23A (Figure 
4E). Collectively, these data provide convincing evidence 
that AB23A-induced autophagic-dependent apoptotic cell 
death through ROS generation.
JNK activation is involved in AB23A-induced 
autophagy and apoptosis
The MAPK pathways which consist of three 
main members, the extracellular signal-regulating 
kinase (ERK), c-Jun N-terminal protein kinase (JNK), 
and p38 has been documented to play important roles 
in autophagy and apoptosis regulation [33, 34]. The 
oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-
28-oic acid (CDDO), its C-28 methyl ester (CDDOMe) 
and C-28 imidazolide ester (CDDO-Im) derivatives-
induced apoptosis in ML-1 and U-937 leukemia cells has 
been demonstrated to be associated with JNK activation 
[35]. Having established that the apoptotic cell death 
induced by AB23A required ROS generation, we then 
Figure 5: ROS generation is upstream of JNK activation and JNK activation is required for the autophagic-dependent 
apoptotic cell death induced by AB23A. (A) Cell viability of HCT116 cells treated with AB23A (20 μM) for 24 h in the presence or 
absence of the MEK1/2 inhibitor U0126 (10 μM), the JNK inhibitor SP600125 (10 μM), or the p38 inhibitor SB203580 (10 μM). (B) Western 
blot analysis of p-JNK, JNK, p-ERK, ERK, p-p38, p38, and β-actin in HCT116 cells treated with AB23A at indicated concentrations for 
24 h. (C) HCT116 cells were treated with AB23A (20 μM) for 24 h in the presence or absence of SP600125 (10 mM). Then the expression 
levels of phospho-JNK, JNK, LC3-II, and PARP were analyzed by Western blot assay and (D) the percentage of apoptotic cells was 
measured by flow cytometry. (E) Western blot analysis of p-JNK and JNK levels in HCT116 cells treated with AB23A (20 μM) for 24 h in 
the presence or absence of NAC (10 mM). Values are mean ± standard deviation, n=3, *p<0.05, **p<0.01.
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asked whether AB23A-induced apoptosis required MAPK 
activation. HCT116 cells were thus exposed to AB23A 
for 24 h together with or without various MAP kinase 
inhibitors that blocked a specific signaling pathway 
leading to cell death. The JNK inhibitor SP600125, but 
not the p38 inhibitor SB203580, nor the ERK inhibitor 
U0126, could partially rescue the loss of cell viability 
caused by AB23A (Figure 5A), suggesting that AB23A 
likely induced cell death via the JNK signaling pathway. 
JNK, ERK, and p38 MAPK activation in response to 
AB23A were then examined in HCT116 cells. As shown in 
Figure 5B, AB23A increased the level of phosphorylated 
JNK, while having a minimum effect on the expression 
of phosphorylated ERK and p38, substantiating the 
involvement of JNK-associated signaling pathway in 
AB23A-induced colon cancer cell death. We then asked 
whether AB23A-induced autophagy and apoptosis 
requires JNK activation. As shown in Figure 5C and 5D, 
the JNK inhibitor SP600125 significantly attenuated LC3-
II and cleaved PARP level and the percentage of apoptotic 
cells in response to AB23A treatment, indicating that the 
JNK pathway was involved in AB23A-induced autophagy 
and apoptosis.
ROS has been reported to be a potent regulator of 
MAP kinase family members and subsequent cell death 
[35, 36]. The above observation confirmed that AB23A-
induced autophagy and apoptotic cell death is dependent 
on intracellular ROS generation and activation of JNK. 
To further elucidate the relationship between ROS and 
JNK in AB23A-induced cell death, the effect of NAC 
on JNK activation was investigated. As shown in Figure 
5E, NAC markedly suppressed AB23A-induced JNK 
phosphorylation, suggesting ROS is upstream of JNK 
activation in AB23A-induced cell death. Taken together, 
these results suggested that AB23A induced autophagic-
dependent apoptotic cell death in human colon cancer cells 
via ROS generation and subsequent JNK activation
Collectively, we have revealed that AB23A, a 
protostane-type triterpenoid from the Chinese herb Alisma 
orientale elicited potent anticancer effect in human colon 
cancer cells by inducing cell cycle arrest and autophagic-
dependent apoptotic cell death. Induction of ROS 
generation and subsequent activation of JNK may account 
for the pharmacological effects of AB23A (Figure 6). 
AB23A may be a promising molecule in colon cancer 
treatment which merits further investigation.
Figure 6: Schematic illustration of the mechanisms of AB23A-induced autophagy and apoptosis in HCT116 cells.
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MATERIALS AND METHODS
Chemical reagents and antibodies
2′,7′-Dichlorodihydrofluorescin diacetate (DCFH-
DA) (sc-359840), N-acetyl-L-cysteine (NAC) (sc-
202232), Z-VAD-FMK (sc-3067) was obtained from 
Santa Cruz. 3-methyladenine (3-MA) (M9281), U0126 
monoethanolate (U120), SP600125 (s5567), and 
SB203580 (S8307) were purchased from Sigma. Primary 
antibodies against p-ERK1/2 Thr202/Tyr204 (4370), ERK1/2 
(9102), p-JNK (9251), JNK (9252), p-p38 (4511), p38 
(8690), PARP (9541), β-Actin (4967), and anti-mouse 
(7076) and anti-rabbit (7074) HRP conjugated secondary 
antibodies were obtained from Cell Signaling Technology. 
AB23A was obtained from National Institutes for Food 
and Drug Control (111846) with a purity of ≥ 98%. 
MitoTEMPOL (ab144644) was purchased from abcam. 
Apocynin (C10076750) was obtained from Macklin.
Cell culture and cell viability assay
Human colon cancer cell lines SW620 and HCT116, 
human normal colon epithelial cell line CCD-841CoN, 
human kidney cancer cell line HEK293T, human gastric 
cancer cell line AGS, and human liver cancer cell line 
PLC8024 were purchased from the American Type 
Culture Collection (ATCC). The cells were maintained 
in DMEM (GIBCO, 12100-061) containing 10% fetal 
bovine serum (GIBCO, 10270) at 37°C under 5% carbon 
dioxide. CCD-841CoN cells were cultured in minimum 
essential medium (MEM) (GIBCO, 11095-080) with 10% 
fetal bovine serum (FBS) under the same conditions for 
the colon cancer cells. Cell viability was measured using 
a cell counting kit (cck-8) (Dojindo, CK-04) according to 
the manufacturer’s instructions. Briefly, cells (1×104 cells/
well) were seeded in 96-well microtiter plates overnight, 
treated with the respective agents for 24 h, and then 
incubated with cck-8 solution (10%) dissolved in the 
culture medium for 1 h at 37°C. Absorbance was measured 
at 450 nm on a Benchmark Plus microplate reader.
Cell cycle analysis
Cells were treated with AB23A (25 μM) or vehicle 
for 24 h, harvested and fixed with cold ethanol (75%) at 
-20°C overnight. Cells were then washed twice with ice-
cold PBS and stained with 50 μg/mL of propidium iodide 
(PI) (Sigma-Aldrich, P4170) in PBS containing 0.1% 
TritonX-100 (Sigma-Aldrich, T8787) and 100 μg/mL of 
RNAse-A (Invitrogen, 12091021) for at least 30 min in the 
dark. The cells were then analyzed using a flow cytometer 
(BD FACSAria III).
Apoptosis assay
Apoptotic chromatin condensation was examined 
by fluorescent microscopy using Hoechst 33342 
(0.5 μg/ml, Sigma-Aldrich, B2261) according to some 
previous studies [9, 10]. In brief, cells were exposed to 
the respective agents for 24 h and then incubated with 
Hoechst 33342 at 37°C for 30 min. After staining, the 
cells were washed three times with PBS, fixed in 4% 
paraformaldehyde, and then observed under a fluorescence 
microscope.
Apoptotic cells were quantified by Annexin V-FITC 
Apoptosis Detection Kit I (556547, BD Pharmingen) using 
flow cytometry according to the protocol provided. Briefly, 
cells were treated with the respective agents for 24 h and 
then washed with PBS and re-suspended in the binding 
buffer. After being incubated with annexin V–FITC (5 μL) 
and PI (10 μL, 50 μg/mL in PBS) mixture in the binding 
buffer (100μL) for 15 min at room temperature in the dark, 
400 μL of binding buffer was added to each tube. The cells 
were then immediately analyzed on a flow cytometer (BD 
FACSAria III).
Intracellular ROS generation assay
Intracellular ROS generation was measured by a 
ROS assay with DCFH-DA using flow cytometry according 
to a previous study [37]. Briefly, cells were plated on a six-
well plate at a density of 5×105 cells/well. After treatment 
with the respective agents for 6 h, the cells were washed 
with PBS and incubated with 10 μM DCFH-DA for 30 min 
at 37°C. The cells were then collected, washed with PBS, 
and analyzed immediately using a flow cytometer (BD 
FACSAria III). The mean fluorescence intensity of 10,000 
cells was analyzed by BD FACSDIVA software.
Western blotting assays
Cells (5×105 cells/well) were seeded on a six-well 
plate overnight, and exposed to the respective agent 
for 24 h. Following the exposure, the cells were rinsed 
with PBS and lysed in RIPA buffer (89900, Thermo 
Scientific) containing protease inhibitor cocktail (Sigma, 
P8340), phosphatase inhibitor cocktail 2 (Sigma-Aldrich, 
P5726) and phosphatase inhibitor cocktail 3 (Sigma-
Aldrich, P0044). Protein concentration was quantified 
using a Bio-Rad protein assay kit (Bio-Rad, 500-0006). 
Lysate proteins (10 μg) were separated on a 10% or 12% 
sodium dodecyl sulfate (SDS)–polyacrylamide gel and 
then electrophoretically transferred onto polyvinylidene 
difluoride (PVDF) membranes (Bio-Rad, 162-0177). 
The membranes were blocked with 5% nonfat milk 
or BSA in TBST for 1 h at room temperature and then 
incubated with the respective primary antibodies at 4°C 
overnight. After being washed five times with TBST, 
the membranes were incubated with the appropriate 
horseradish peroxidase-conjugated secondary antibodies 
for 1 h at room temperature. Protein bands were visualized 
by chemiluminescence detection kit (Thermo Fisher 
Scientific, 1856135). Densitometric quantification was 
performed using ImageJ software (National Institute of 
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Health, Bethesda, MD, USA). β-Actin served as a loading 
control.
Statistical analysis
All experimental data were the average of at least 
3 independent tests. Differences between experimental 
groups were calculated using Student’s t-test. A p-value 
less than 0.05 was considered as statistically significant.
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